SOA Wealth Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-41
Closed -$3.73K 886
2025
Q1
$3.73K Hold
41
﹤0.01% 659
2024
Q4
$4.67K Hold
41
﹤0.01% 626
2024
Q3
$4.87K Hold
41
﹤0.01% 607
2024
Q2
$3.29K Hold
41
﹤0.01% 637
2024
Q1
$3.78K Hold
41
﹤0.01% 639
2023
Q4
$4.33K Hold
41
﹤0.01% 615
2023
Q3
$4.45K Hold
41
﹤0.01% 632
2023
Q2
$4.42K Hold
41
﹤0.01% 637
2023
Q1
$5.11K Hold
41
﹤0.01% 620
2022
Q4
$6.16K Hold
41
﹤0.01% 590
2022
Q3
$5K Hold
41
﹤0.01% 597
2022
Q2
$6K Hold
41
﹤0.01% 559
2022
Q1
$6K Hold
41
﹤0.01% 652
2021
Q4
$10K Hold
41
﹤0.01% 564
2021
Q3
$11K Hold
41
﹤0.01% 564
2021
Q2
$9K Sell
41
-121
-75% -$22.8K ﹤0.01% 587
2021
Q1
$17K Hold
162
﹤0.01% 429
2020
Q4
$19K Buy
+162
New +$15.9K 0.01% 409

Other funds holding BNTX

SOA Wealth Advisors's BNTX Position: Q2 2025 in Review

SOA Wealth Advisors sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 41 shares — an estimated $3.73K sold.

SOA Wealth Advisors first reported a position in BNTX in Q4 2020 and held it in 18 quarters. The position peaked at $19K in Q4 2020. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • SOA Wealth Advisors reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • SOA Wealth Advisors sold 41 BioNTech shares in Q2 2025, an estimated $3.73K.
  • SOA Wealth Advisors first reported a position in BioNTech in Q4 2020 and held it in 18 quarters.
  • SOA Wealth Advisors's BioNTech position peaked at $19K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on SOA Wealth Advisors's 13F filing for Q2 2025, filed 18 Jul 2025.